Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

Process for Tracking Utilization of COVID-19 Therapeutics

Registering/entering data into Teletracking (for applicable sites)

Weekly reporting on use of federally purchased COVID-19 therapeutics is required every Wednesday. Sites that use these therapies are required to report through HHS Protect, TeleTracking, or CDC’s National Healthcare Safety Network (NHSN) depending on facility type.

Who Should Report:

  • Hospitals report their COVID-19 therapeutics information as part of their overall COVID-19 capacity and utilization reporting and are not required to provide separate reports

  • Long-term care facilities and/or skilled nursing facilities are required to report utilization through NHSN and are not required to provide separate reports

  • All other sites (e.g., urgent care centers, infusion centers, dialysis centers, etc.) are to report utilization of therapies through their individual TeleTracking accounts

Step 1: Registration

  • Using the invitation link in your email (from:, create a username and password 1
  • This link only works for the first use

Step 2: Invite other team members 

Step 3: Entering data into TeleTracking  

  • For each of the products in the Therapeutics section, enter in quantity of product used in the last week and quantity remaining on hand and press submit
  • The numbers should be in patient courses (e.g. number of patients that are treated/could be treated given available stock on hand)         

    Screenshot of the Teletracking Therapeutics section

Sites are required to enter administration and stock on hand data by Wednesday each week, compliance is tracked by TeleTracking.  

​For additional support (24/7):



1  If you do not have a TeleTracking account, one will be established for your center after placing your first order. You will receive enrollment and reporting instructions in an e-mail from with the subject line of “Invitation: HHS TeleTracking COVID-19 Portal.” If you do not receive an within 48 hours within placing your order, please contact TeleTracking’s Technical Support at


​Special Projects for Equitable and Efficient Distribution (SPEED)

COVID-19 Monoclonal Antibody Therapeutics

  • This page last reviewed: May 17, 2021